Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries.
Leblebicioglu H, Arama V, Causse X, Marcellin P, Ozaras R, Postawa-Klozinska B, Simon K, Suceveanu AI, Wiese M, Zeuzem S, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Zarski JP; AI463-121 European Longitudinal Chronic Hepatitis B Study Group. Leblebicioglu H, et al. Among authors: lescrauwaet b. J Viral Hepat. 2014;21(9):662-70. doi: 10.1111/jvh.12202. Epub 2013 Dec 15. J Viral Hepat. 2014. PMID: 24329883
The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis.
Mealing S, Ghement I, Hawkins N, Scott DA, Lescrauwaet B, Watt M, Thursz M, Lampertico P, Mantovani L, Morais E, Bregman B, Cucherat M. Mealing S, et al. Among authors: lescrauwaet b. Syst Rev. 2014 Mar 7;3:21. doi: 10.1186/2046-4053-3-21. Syst Rev. 2014. PMID: 24602249 Free PMC article. Review.
Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies.
Arama V, Leblebicioglu H, Simon K, Zarski JP, Niederau C, Habersetzer F, Vermehren J, Bludzin W, Jinga M, Ulusoy S, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Zeuzem S; AI463-121 European Longitudinal Chronic Hepatitis B Study Group. Arama V, et al. Among authors: lescrauwaet b. Antivir Ther. 2014;19(3):245-57. doi: 10.3851/IMP2719. Epub 2013 Dec 17. Antivir Ther. 2014. PMID: 24343051
Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study.
Marcellin P, Arama V, Leblebicioglu H, Zarski JP, Zeuzem S, Mauss S, Sieklucki J, Acalovschi M, Usluer G, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Simon K; AI463-121 European Longitudinal Chronic Hepatitis B Study Group. Marcellin P, et al. Among authors: lescrauwaet b. Antivir Ther. 2014;19(3):235-43. doi: 10.3851/IMP2573. Epub 2013 Apr 10. Antivir Ther. 2014. PMID: 23574686
25 results